Atlas Trials

A Randomized, Double-Blind Trial Comparing the Efficacy and Safety of Fenofibrate, Metformin, Their Combination and Placebo in Patients With Metabolic Syndrome.

Clinical trial NCT00703755 · COMPLETED

Trial details

NCT number
NCT00703755
Sponsor
Solvay Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Patients With Metabolic Syndrome
Start date
2003-03-01
Primary completion
2004-06-01
Enrollment
2288

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.